Leerink Partnrs Has Positive Outlook of RVMD FY2025 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Equities researchers at Leerink Partnrs boosted their FY2025 earnings per share estimates for Revolution Medicines in a research report issued on Thursday, May 8th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($4.68) per share for the year, up from their previous forecast […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Equities researchers at Leerink Partnrs boosted their FY2025 earnings per share estimates for Revolution Medicines in a research report issued on Thursday, May 8th. Leerink Partnrs analyst J. Chang now anticipates that the company will earn ($4.68) per share for the year, up from their previous forecast […]
